Elanix Biotechnologies AG has signed a distribution agreement with MedBioSante to make its progenitor cell-based creams available in Russia. Through this partnership, Elanix will initially sell its products via a gynaecologist prescription network in Moscow before extending its reach through digital sales channels to other Russian cities and the CIS states from next year. GYNrepair(R) cream, which is developed and marketed by Elanix's wholly-owned subsidiary Repair A, contains a proprietary Cell Free Protein Complex (CFPC(R)), including various proteins, such as collagen and fibronectin, and is perfume-free. It is specifically designed for use on the genital external mucosa to soothe the feeling of discomfort, twinges and dryness.